Cleared Traditional

K903441 - MYDAS(TM) BRAND SOLID-PHASE ANTIBODY REAGENTS

K903441 is an FDA 510(k) clearance for MYDAS(TM) BRAND SOLID-PHASE ANTIBODY RE..., manufactured by Intl. Immunoassay Laboratories, Inc.. The device is a Class 2 Chemistry device with product code JHX cleared through the Traditional 510(k) pathway after a 98-day FDA review.

K903441 · Intl. Immunoassay Laboratories, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1990
Decision
98d
Days
Class 2
Risk

K903441 is an FDA 510(k) clearance for the MYDAS(TM) BRAND SOLID-PHASE ANTIBODY REAGENTS. Classified as Fluorometric Method, Cpk Or Isoenzymes (product code JHX), Class II - Special Controls.

Submitted by Intl. Immunoassay Laboratories, Inc. (Santa Clara, US). The FDA issued a Cleared decision on November 6, 1990 after a review of 98 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1215 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Intl. Immunoassay Laboratories, Inc. devices

FDA 510(k) Submission Details - K903441

510(k) Number K903441 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 31, 1990
Decision Date November 06, 1990
Days to Decision 98 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
10d slower than avg
Panel avg: 88d · This submission: 98d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JHX Device Classification - Class 2, Special Controls

Product Code JHX Fluorometric Method, Cpk Or Isoenzymes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1215
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JHX Fluorometric Method, Cpk Or Isoenzymes

All 41
Devices cleared under the same product code (JHX) and FDA review panel - the closest regulatory comparables to K903441.
VIDAS CREATINE KINASE MB ASSAY 30-421
K962549 · Biomerieux Vitek, Inc. · Aug 1996
MYDAS(TM)-MB2/MYDAS(TM)-MB
K913380 · Intl. Immunoassay Laboratories, Inc. · Apr 1992
CIBA CORNING ACS CKMB IMMUNOASSAY
K911121 · Ciba Corning Diagnostics Corp. · Apr 1991
IMPRES-MB REAGENT A AND REAGENT B
K890543 · Intl. Immunoassay Laboratories, Inc. · Mar 1989
BIOTROL CK MONOEACTIF
K881267 · Biotrol, USA, Inc. · May 1988
CREATINE KINASE (CK) REAGENT SET
K881237 · Tech-Neal Scientific, Inc. · Apr 1988